Our Approach Has The Potential To Correct Myelin-Based Deficits In A Range Of Disorders

(About the Author)

Jordana Holovach

Vice President, Head of Communications and Community

Jordana joined the Company in 2021, bringing more than 20 years of experience in leadership roles in the non-profit/rare disease sector.